Cargando…
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
• Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sh...
Autores principales: | Coudeville, L., Gomez, G.B., Jollivet, O., Harris, R.C., Thommes, E., Druelles, S., Chit, A., Chaves, S.S., Mahé, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552977/ https://www.ncbi.nlm.nih.gov/pubmed/33097312 http://dx.doi.org/10.1016/j.vaccine.2020.10.034 |
Ejemplares similares
-
Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study
por: Coudeville, Laurent, et al.
Publicado: (2021) -
Disease transmission and mass gatherings: a case study on meningococcal infection during Hajj
por: Coudeville, Laurent, et al.
Publicado: (2022) -
Large-scale frequent testing and tracing to supplement control of Covid-19 and vaccination rollout constrained by supply
por: Humphrey, Lia, et al.
Publicado: (2021) -
Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective
por: Gómez, Roberto E., et al.
Publicado: (2012) -
Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)